Posts Tagged ‘AFP’
Case overview: Novartis AG and Genentech v SHARx and Campbell Heights Pharmacy (2026 — ) – ongoing
Novartis and Genentech have filed a Lanham Act complaint against an alternative funding program and a Canadian pharmacy allegedly supplying Canadian Xolair to Michigan patients.
[...]Update on drug importation, February 2026
Well-meaning advocates continue to propose importing medicine from foreign countries to lower drug prices for Americans. Past efforts didn’t pay off financially and raised public health risks. Here’s the state of this issue today.
[...]PSM gives testimony in opposition to a Colorado bill to permit alternative funding programs
On February 17, PSM submitted written and oral testimony in opposition to Colorado HB26-1056, which would permit self-insured employers to use alternative funding programs to import foreign medicines from outside the U.S. drug supply chain.
[...]Five takeaways from CNBC’s investigation of alternative funding programs
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
[...]Case overview, Gilead Sciences v Meritain Health, et al (2024 — ) – ongoing
Gilead Sciences filed a Lanham Act complaint against a group of companies that allegedly pushed patients into ordering non-FDA approved international medicines to lower costs in employer-sponsored health insurance plans.
[...]Tell us about your alternative funding program
Used an alternative funding program? Tell us your story The Partnership for Safe Medicines is researching alternative funding programs. If you are a patient or an administrator, we’d like to confidentially interview you to understand how you have encountered these programs, how they work, and what your experience was. If you’re ready to interview, or…
[...]FOIA returns from towns using alternative funding vendors
PSM has sent open records requests to several towns and schools with self-funded health plans about their relationships with alternative funding vendors.
[...]Alternative funding programs offshore patients and import risks
Some employers are “saving money” on health insurance by hiring vendors to broker personal drug importation between their employees and unlicensed, illegal foreign pharmacies. Read more to understand the dangers of this cost-cutting practice.
[...]